These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21873349)

  • 1. Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis.
    Misselt AJ; Zielinski MD; Medina OI; Oderich G; Bjarnason H; McKusick MA; Misra S
    Angiology; 2012 May; 63(4):259-65. PubMed ID: 21873349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.
    Rabellino M; Zander T; Baldi S; Garcia Nielsen L; Aragon-Sanchez FJ; Zerolo I; Llorens R; Maynar M
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):701-5. PubMed ID: 19309709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L; Alric P; Berthet JP; Marty-Ané C; Mercier G; Branchereau P
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of drug-coated balloon angioplasty in patients with femoropopliteal disease: A real-world single-center experience.
    AbuRahma AF; AbuRahma ZT; Scott G; Adams E; Beasley M; Davis M; Dean LS; Davis E
    J Vasc Surg; 2019 Dec; 70(6):1950-1959. PubMed ID: 31401115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia.
    Keeling WB; Shames ML; Stone PA; Armstrong PA; Johnson BL; Back MR; Bandyk DF
    J Vasc Surg; 2007 Jan; 45(1):25-31. PubMed ID: 17210379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
    Grenville JL; Tan KT; Moshonov H; Rajan DK
    Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
    Costanza MJ; Queral LA; Lilly MP; Finn WR
    J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
    Mohr PJ; Oyama JK; Luu JT; Stinis CT
    Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde Popliteal Access to Percutaneous Peripheral Intervention for Chronic Total Occlusion of Superficial Femoral Arteries.
    Dumantepe M
    Vasc Endovascular Surg; 2017 Jul; 51(5):240-246. PubMed ID: 28595481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
    Steiner S; Schmidt A; Scheinert D
    Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Pave-and-Crack" Technique: Technical Description and 12-Month Results.
    Dias-Neto M; Matschuck M; Bausback Y; Banning-Eichenseher U; Steiner S; Branzan D; Staab H; Varcoe RL; Scheinert D; Schmidt A
    J Endovasc Ther; 2018 Jun; 25(3):334-342. PubMed ID: 29557221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
    Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
    J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.